ClinicalTrials.Veeva
Menu

Find clinical trials for COVID-19 in New York, NY

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Infections
Communicable Diseases
Coronavirus Infections
Pneumonia
Human Influenza
Post-Acute COVID-19 Syndrome
Respiratory Distress Syndrome

COVID-19 trials near New York, NY, USA:

AZD7442 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

This study looks at the safety and effectiveness of AZD7442 in treating COVID-19 in people who have been hospitalized with the infe...

Active, not recruiting
COVID-19
Biological: Placebo
Biological: Remdesivir

Phase 3

National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)

Brooklyn, New York, United States and 123 other locations

for infectious pneumonia acquired in the community (CAP), including COVID-19.Secondary objectives:- To determine the effect of repa...

Enrolling
Severe COVID-19
Infectious Pneumonia
Other: Placebo
Drug: Reparixin

Phase 3

Dompé
Dompé

New York, New York, United States and 106 other locations

This study is designed to demonstrate the performance and usability of the the Panbio™ COVID-19/Flu A\&B Panel Self Test in the han...

Enrolling
COVID-19
Influenza A
Diagnostic Test: Panbio™ COVID-19/Flu A&B Panel
Abbott
Abbott

Brooklyn, New York, United States and 1 other location

A randomized, double-blind, placebo-controlled Phase 2/3 Study of LAU-7b against confirmed COVID-19 Disease in hospitalized patient...

Active, not recruiting
COVID-19 Disease
Drug: Placebo oral capsule
Drug: LAU-7b

Phase 2, Phase 3

Laurent Pharmaceuticals

Staten Island, New York, United States and 28 other locations

The purpose of this study is to evaluate the safety, reactogenicity, and relative vaccine efficacy (rVE) of the mRNA-1283.222 vaccine as well as its...

Active, not recruiting
COVID-19
Biological: mRNA-1273.222
Biological: mRNA-1283.222

Phase 3

Moderna
Moderna

New York, New York, United States and 217 other locations

The primary objective of this study is to evaluate the safety and tolerability of intravenous (IV) IMM-BCP-01 in subjects with mild to moderate COVID...

Enrolling
COVID-19
SARS-CoV2 Infection
Drug: Placebo
Drug: IMM-BCP-01

Phase 1

Immunome, Inc.

New York, New York, United States and 2 other locations

an immunotherapy containing Natural Killer (NK) cells derived from human placental CD34+ cells and culture-expanded, in patients with moderate COVID...

Active, not recruiting
Analgesics
Antimetabolites, Antineoplastic
Biological: CYNK-001

Phase 1, Phase 2

Celularity

Hackensack, New Jersey, United States and 6 other locations

is to assess the safety and efficacy of leronlimab (PRO 140) administered as weekly subcutaneous injection in subjects with severe or critical COVID...

Active, not recruiting
Coronavirus Disease 2019
Drug: Leronlimab (700mg)
Drug: Placebos

Phase 2

CytoDyn

Brooklyn, New York, United States and 17 other locations

seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...

Enrolling
COVID-19
Parainfluenza
Drug: DAS181 COVID-19
Drug: DAS181

Phase 3

Ansun Biopharma

New York, New York, United States and 59 other locations

The purpose of this study is to understand the safety and effects of a combined influenza and COVID-19 vaccine. This combined vacci-...

Active, not recruiting
COVID-19
Influenza
Biological: COVID-19 Vaccine
Biological: Influenza and COVID-19 Combination A

Phase 3

BioNTech
BioNTech

New York, New York, United States and 157 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems